statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	534
SG - Singapore	138
CN - Cina	66
DE - Germania	57
HK - Hong Kong	54
BR - Brasile	44
IT - Italia	23
FI - Finlandia	22
GB - Regno Unito	20
VN - Vietnam	20
FR - Francia	19
TR - Turchia	18
IN - India	14
RU - Federazione Russa	12
IE - Irlanda	11
BD - Bangladesh	8
UA - Ucraina	8
IQ - Iraq	7
CA - Canada	6
PL - Polonia	6
ZA - Sudafrica	6
JP - Giappone	5
MX - Messico	5
SE - Svezia	5
AR - Argentina	4
AE - Emirati Arabi Uniti	3
BG - Bulgaria	3
ES - Italia	3
NL - Olanda	3
SK - Slovacchia (Repubblica Slovacca)	3
CZ - Repubblica Ceca	2
EG - Egitto	2
IL - Israele	2
KR - Corea	2
LV - Lettonia	2
MA - Marocco	2
PK - Pakistan	2
SY - Repubblica araba siriana	2
UZ - Uzbekistan	2
AL - Albania	1
AU - Australia	1
DM - Dominica	1
DZ - Algeria	1
EC - Ecuador	1
ET - Etiopia	1
HU - Ungheria	1
ID - Indonesia	1
KE - Kenya	1
KH - Cambogia	1
KZ - Kazakistan	1
LA - Repubblica Popolare Democratica del Laos	1
LT - Lituania	1
PA - Panama	1
PE - Perù	1
RS - Serbia	1
SV - El Salvador	1
TM - Turkmenistan	1
TV - Tuvalu	1
UY - Uruguay	1
VE - Venezuela	1
Totale	1.166

Nome	#
COVID-19 Pneumonia, Takotsubo Syndrome, and Left Ventricle Thrombi	115
Full Endovascular Management in Simultaneous Ischeamic and Bleeding Complications during Covid 19 Pandemic in Northern Italy.	109
Endothelial function evaluation in idiopathic vs. ischemic dilated cardiomyopathy	108
Sinus Node Dysfunction in a Young Patient With COVID-19	108
COVID 19 Pneumonia. Takotsubo syndrome and left ventricular thrombi.	105
Cardiac biomarkers and mortality in COVID-19 infection: A review	101
Study of endothelial function and vascular stiffness in patients affected by dilated cardiomyopathy on treatment with sacubitril/valsartan	98
Endothelial dysfunction in COVID-19 patients assessed with Endo-PAT2000	96
Cardiogenic Shock due to COVID-19-Related Myocarditis in a 19-Year-Old Autistic Patient	90
Thrombotic risk in patients with COVID-19	90
Unusual intracardiac thrombosis in two patients with coronavirus disease 2019 (COVID-19): case series	80
The prevalence and incidence of thrombotic primary antiphospholipid syndrome in adults aged 18-49 years: A population-based study in a mountain community in northern Italy	73
Totale	1.173

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	1	0	0	0	0	0	0	0	0	0	0	0	1
2021/2022	37	2	3	0	2	1	3	1	2	0	3	5	15
2022/2023	104	11	14	8	7	9	25	0	8	9	0	10	3
2023/2024	126	3	1	22	5	6	38	2	2	28	4	0	15
2024/2025	266	10	11	4	29	13	31	12	17	28	36	43	32
2025/2026	583	60	75	27	94	83	35	104	12	38	45	10	0
Totale													1.173